<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01752309</url>
  </required_header>
  <id_info>
    <org_study_id>MEC2009-333</org_study_id>
    <secondary_id>NL28038.078.09</secondary_id>
    <nct_id>NCT01752309</nct_id>
  </id_info>
  <brief_title>The Predictive Value of Ultrasound in Early Rheumatoid Arthritis</brief_title>
  <acronym>EVA</acronym>
  <official_title>The Predictive Value of Ultrasound in Early Rheumatoid Arthritis</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Erasmus Medical Center</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Maasstad Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Albert Schweitzer Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Vlietland Ziekenhuis</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>UMC Utrecht</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Medical Center Alkmaar</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Ziekenhuisgroep Twente</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Erasmus Medical Center</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Rheumatoid arthritis a chronic and progressive inflammatory disease characterized by synovial
      membrane inflammation, possibly leading to destruction of joints. To start early with a
      combination therapy results in a better outcome for patients. Using ultrasonography it is
      possible to detect clinically and radiographically absent synovitis and erosions. However, it
      is unclear whether or not these findings have predictive value in these patients regarding
      disease activity or radiographical progression.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Patients will be evaluated using the standard diagnostic workup of patients with early
      arthritis. This includes history taking, physical examination, Disease Activity Score of 44
      joints (DAS44) and a laboratory test, including C-Reactive Protein(CRP), Erythrocyte
      Sedimentation Rate (ESR), Complete Blood Count (CBC), Rheumatoid Factor (RF), Anti-Cyclic
      Citrullinated Peptide(anti-CCP), transaminases, urinanalysis.

      Also part of the standard workup for these patients are X-Rays of hands and feet to detect
      erosions. The baseline medication will include - in concordance with European League Against
      Rheumatism (EULAR)-guidelines and the provisional 'Nederlandse Vereniging voor
      Reumatologie(NVR)'-guidelines - Methotrexate (MTX) for all patients. The medicine regimes are
      part of the ongoing cohort studies from which the patients will be recruited. Evaluating the
      medicine effects is not part of the 'Echografie bij Vroege Artritis (EVA)(Ultrasound in Early
      Arthritis)' study. All consecutive Rheumatoid Arthritis (RA) patients will be asked to
      participate in this study. They will receive oral and written information about the EVA
      study.

      Approximately two weeks after this first consultation the patient returns to his or her
      rheumatologist for the diagnosis and accompanying treatment. If the patient decides to
      participate in this study they fill out the informed consent form. The patient will be asked
      to fill out the Health Assessment Questionnaire (HAQ) and the Short Form-36 (SF-36). After
      this, at baseline, at three months and at 12 months, Metatarsophalangeal (MTP) 2-5(dorsal
      aspect) and Metacarpophalangeal (MCP) 2-5(dorsal, palmar, lateral) and wrists of each patient
      will be examined with ultrasound by a single rheumatologist per centre specialized in
      Ultrasound (US). This rheumatologist will be unaware of the clinical, laboratory and
      radiographic findings.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>June 2010</start_date>
  <completion_date type="Actual">July 2013</completion_date>
  <primary_completion_date type="Actual">July 2013</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Persistence of active disease after one year, defined as a Disease Activity Score of 44 joints (DAS44) &gt; 3.4</measure>
    <time_frame>One year after inclusion in the study</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Change in Sharp vd Heijde score during the year of inclusion</measure>
    <time_frame>At date of inclusion and after one year</time_frame>
  </secondary_outcome>
  <other_outcome>
    <measure>Change of DAS over time</measure>
    <time_frame>At date of inclusion, after 3 months and after one year</time_frame>
  </other_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Actual">150</enrollment>
  <condition>Rheumatoid Arthritis</condition>
  <condition>Predictive Value of Ultrasound in Early Rheumatoid Arthritis</condition>
  <arm_group>
    <arm_group_label>Rheumatoid Arthritis, ultrasound, persistence disease activity</arm_group_label>
    <description>Patients diagnosed with early Rheumatoid Arthritis will be assessed three times in one year with ultrasound to evaluate the predictive value of ultrasound.</description>
  </arm_group>
  <eligibility>
    <study_pop>
      <textblock>
        Starting in June 2010, all newly diagnosed rheumatoid arthritis patients who will be
        participating in 2 ongoing trials will be invited to participate in this study. In Almelo
        they will be recruited from the outpatient Rheumatology clinic.
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Newly diagnosed rheumatoid arthritis patients, diagnosed according to the American
             College of Rheumatology (ACR) 1987-criteria

          -  Na√Øve for Disease Modifying Anti Rheumatic Drugs (DMARDs), biologicals and
             glucocorticoids.

          -  Starting with treatment with a potent anti-rheumaticum. E.g. methotrexate (MTX),
             biologicals or glucocorticoids.

        Exclusion Criteria:

          -  Contra-indications for MTX, biologicals or glucocorticoids.

          -  Insufficient ability to read and write in Dutch

          -  Personality disorders that limit the participation in the study
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Jolanda J. Luime, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Erasmus Medical Center</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Medical Center Alkmaar</name>
      <address>
        <city>Alkmaar</city>
        <state>Noord Holland</state>
        <zip>1815JD</zip>
        <country>Netherlands</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Ziekenhuisgroep Twente</name>
      <address>
        <city>Almelo</city>
        <state>Overijssel</state>
        <zip>7609PP</zip>
        <country>Netherlands</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Albert Schweitzer Hospital</name>
      <address>
        <city>Dordrecht</city>
        <state>Zuid Holland</state>
        <zip>3300AK</zip>
        <country>Netherlands</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Erasmus Medical Center</name>
      <address>
        <city>Rotterdam</city>
        <state>Zuid Holland</state>
        <zip>3015GE</zip>
        <country>Netherlands</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Maasstad Hospital</name>
      <address>
        <city>Rotterdam</city>
        <state>Zuid Holland</state>
        <zip>3079DZ</zip>
        <country>Netherlands</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Vlietland Hospital</name>
      <address>
        <city>Schiedam</city>
        <state>Zuid Holland</state>
        <zip>3118JH</zip>
        <country>Netherlands</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>University Medical Center Utrecht</name>
      <address>
        <city>Utrecht</city>
        <zip>3584CX</zip>
        <country>Netherlands</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Netherlands</country>
  </location_countries>
  <verification_date>November 2014</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>December 12, 2012</study_first_submitted>
  <study_first_submitted_qc>December 14, 2012</study_first_submitted_qc>
  <study_first_posted type="Estimate">December 19, 2012</study_first_posted>
  <last_update_submitted>November 18, 2014</last_update_submitted>
  <last_update_submitted_qc>November 18, 2014</last_update_submitted_qc>
  <last_update_posted type="Estimate">November 19, 2014</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Erasmus Medical Center</investigator_affiliation>
    <investigator_full_name>Ten Cate</investigator_full_name>
    <investigator_title>David F. Ten Cate, MD</investigator_title>
  </responsible_party>
  <keyword>Early Rheumatoid arthritis</keyword>
  <keyword>Rheumatoid arthritis</keyword>
  <keyword>Ultrasound</keyword>
  <keyword>Predictive</keyword>
  <keyword>Prognosis</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Arthritis</mesh_term>
    <mesh_term>Arthritis, Rheumatoid</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

